Diagnostics, Immunology, Cardiology. Company provides a diagnostic assay measuring the blood plasma levels of myeloperoxidase, a critical immune system protein enzyme whose lack of, or deficiency, leads to severely compromised immune system function. It also offers a novel cardiovascular biomarker diagnostic for coronary artery disease, that when used in conjunction with current examinations such as cholesterol tests, provides improved and more precise disease risk assessment. The company currently has a vast pipeline of cardiovascular and inflammatory biomarkers, and is seeking funding to solidify its biomarker franchise and to launch a more comprehensive disease management program. Its specialty reference laboratory is accredited by the College of American Pathologists (CAP). Founded: 2004, Employees: 13.